argenx BVBA
13Patents
13Active
13Granted
44Portfolio score
Filing activity: Sep 2, 2013 → Feb 14, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10316073B2 | FCRN antagonists and methods of use | Chemistry; Metallurgy | 6 | Active |
| US10040870B2 | Highly diverse combinatorial antibody libraries | Chemistry; Metallurgy | 5 | Active |
| US11072665B2 | Antibodies to CD70 | Chemistry; Metallurgy | 2 | Active |
| US10479829B2 | GARP-TGF-beta 1 antibodies | Chemistry; Metallurgy | 1 | Active |
| US10487156B2 | Asymmetric multispecific antibodies | Chemistry; Metallurgy | 1 | Active |
| US11161900B2 | Antibodies that specifically bind to human complement factor C2b | Chemistry; Metallurgy | 1 | Active |
| US10696741B2 | Anti-IL-22R antibodies | Chemistry; Metallurgy | 1 | Active |
| US10676535B2 | Anti c-Met antibodies | Chemistry; Metallurgy | 0 | Active |
| US10793627B2 | GARP-TGF-β 1 IGG antibodies | Chemistry; Metallurgy | 0 | Active |
| US10875914B2 | Nucleic acids encoding GARP-TGF-beta 1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11117959B2 | IL-6 binding molecules | Chemistry; Metallurgy | 0 | Active |
| US11230603B2 | Anti-GARP protein | Chemistry; Metallurgy | 0 | Active |
| US10604579B2 | Antibody against a complex between human GARP and latent TGF-β | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.